Toxin Synthesis by Clostridium difficile Is Regulated through Quorum Signaling

被引:84
作者
Darkoh, Charles [1 ]
DuPont, Herbert L. [1 ,4 ,5 ]
Norris, Steven J. [2 ,3 ]
Kaplan, Heidi B. [2 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Ctr Infect Dis, Houston, TX 77030 USA
[2] Univ Texas Med Sch, Dept Microbiol & Mol Genet, Houston, TX USA
[3] Univ Texas Med Sch, Dept Pathol & Lab Med, Houston, TX USA
[4] St Lukes Med Ctr, Internal Med, Houston, TX USA
[5] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
来源
MBIO | 2015年 / 6卷 / 02期
关键词
GENE-EXPRESSION; SENSING SYSTEM; STRAINS; DISEASE; IDENTIFICATION; TRANSCRIPTION; ACTIVATION; VIRULENCE; EPIDEMIC; LOCUS;
D O I
10.1128/mBio.02569-14
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Clostridium difficile infection (CDI) is dramatically increasing as a cause of antibiotic-and hospital-associated diarrhea worldwide. C. difficile, a multidrug-resistant pathogen, flourishes in the colon after the gut microbiota has been altered by antibiotic therapy. Consequently, it produces toxins A and B that directly cause disease. Despite the enormous public health problem posed by this pathogen, the molecular mechanisms that regulate production of the toxins, which are directly responsible for disease, remained largely unknown until now. Here, we show that C. difficile toxin synthesis is regulated by an accessory gene regulator quorum-signaling system, which is mediated through a small (< 1,000-Da) thiolactone that can be detected directly in stools of CDI patients. These findings provide direct evidence of the mechanism of regulation of C. difficile toxin synthesis and offer exciting new avenues both for rapid detection of C. difficile infection and development of quorum-signaling-based non-antibiotic therapies to combat this life-threatening emerging pathogen. IMPORTANCE Clostridium difficile infection (CDI) is the most common definable cause of hospital-acquired and antibiotic-associated diarrhea in the United States, with the total cost of treatment estimated between 1 and 4.8 billion U.S. dollars annually. C. difficile, a Gram-positive, spore-forming anaerobe, flourishes in the colon after the gut microbiota has been altered by antibiotic therapy. As a result, there is an urgent need for non-antibiotic CDI treatments that preserve the colonic microbiota. C. difficile produces toxins A and B, which are directly responsible for disease. Here, we report that C. difficile regulates its toxin synthesis by quorum signaling, in which a novel signaling peptide activates transcription of the disease-causing toxin genes. This finding provides new therapeutic targets to be harnessed for novel nonantibiotic therapy for C. difficile infections.
引用
收藏
页数:10
相关论文
共 48 条
[1]   Clostridium difficile infection: epidemiology, risk factors and management [J].
Ananthakrishnan, Ashwin N. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2011, 8 (01) :17-26
[2]   TcdC Does Not Significantly Repress Toxin Expression in Clostridium difficile 630ΔErm [J].
Bakker, Dennis ;
Smits, Wiep Klaas ;
Kuijper, Ed J. ;
Corver, Jeroen .
PLOS ONE, 2012, 7 (08)
[3]   The new Clostridium difficile -: What does it mean? [J].
Bartlett, JG ;
Perl, TM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) :2503-2505
[4]   Identification of genes involved in cytochrome c biogenesis in Shewanella oneidensis, using a modified mariner transposon [J].
Bouhenni, R ;
Gehrke, A ;
Saffarini, D .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2005, 71 (08) :4935-4937
[5]   The Essential Escherichia coli Apolipoprotein N-Acyltransferase (Lnt) Exists as an Extracytoplasmic Thioester Acyl-Enzyme Intermediate [J].
Buddelmeijer, Nienke ;
Young, Ry .
BIOCHEMISTRY, 2010, 49 (02) :341-346
[6]   Fecal Transplantation for Recurrent Clostridium difficile Infection in Older Adults: A Review [J].
Burke, Kristin E. ;
Lamont, John T. .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 (08) :1394-1398
[7]   The Anti-Sigma Factor TcdC Modulates Hypervirulence in an Epidemic BI/NAP1/027 Clinical Isolate of Clostridium difficile [J].
Carter, Glen P. ;
Douce, Gillian R. ;
Govind, Revathi ;
Howarth, Pauline M. ;
Mackin, Kate E. ;
Spencer, Janice ;
Buckley, Anthony M. ;
Antunes, Ana ;
Kotsanas, Despina ;
Jenkin, Grant A. ;
Dupuy, Bruno ;
Rood, Julian I. ;
Lyras, Dena .
PLOS PATHOGENS, 2011, 7 (10)
[8]   Precise Manipulation of the Clostridium difficile Chromosome Reveals a Lack of Association between the tcdC Genotype and Toxin Production [J].
Cartman, Stephen T. ;
Kelly, Michelle L. ;
Heeg, Daniela ;
Heap, John T. ;
Minton, Nigel P. .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2012, 78 (13) :4683-4690
[9]   Role of the Agr-Like Quorum-Sensing System in Regulating Toxin Production by Clostridium perfringens Type B Strains CN1793 and CN1795 [J].
Chen, Jianming ;
McClane, Bruce A. .
INFECTION AND IMMUNITY, 2012, 80 (09) :3008-3017
[10]   tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile [J].
Curry, Scott R. ;
Marsh, Jane W. ;
Muto, Carlene A. ;
O'Leary, Mary M. ;
Pasculle, A. William ;
Harrison, Lee H. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (01) :215-221